Wall Street Journal

Toy company Hasbro Inc (NASDAQ:HAS) announced a workforce reduction on Tuesday as the company grapples with tariff impacts. What To Know: Hasbro cut 3% of its global workforce, or approximately 150 employees, across multiple divisions and regions around the globe, The Wall Street Journal reported...

On Monday, the U.S. Secretary of Health and Human Services, Robert F. Kennedy Jr., decided to fire all 17 members of the Advisory Committee on Immunization Practices, a panel that plays a key role in shaping U.S. vaccine policy. What Happened: In an op-ed published in the Wall Street Journal,...

Silicon carbide component manufacturer Wolfspeed Inc. (NYSE:WOLF) is preparing to file for prepackaged Chapter 11 bankruptcy protection in the coming weeks. What Happened: Facing mounting debt and failed out-of-court restructuring talks with key creditors, the company is reportedly...

Jim Cramer weighed in on the deepening crisis at one of America’s largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media. What Happened: On Thursday, Cramer commented on UnitedHealth Group Inc.'s (NYSE:UNH) mounting troubles,...

Microsoft Corp (NASDAQ:MSFT) and Amazon.com Inc (NASDAQ:AMZN) Web Services could come under scrutiny from U.K. regulators after an independent investigation found a lack of competition in the cloud-services market. What To Know: The U.K. Competition and Markets Authority (CMA) announced Tuesday ...

When Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) bought See's Candies in 1972, the firm’s late vice chairman, Charlie Munger, learned a valuable lesson that would end up guiding his investing career. The company raised prices without hurting...

Sen. Chuck Schumer (D-N.Y.) expressed his admiration for journalist Evan Gershkovich, who recently returned to the U.S. after a wrongful detention in Russia. What Happened: On Tuesday, Schumer posted about his meeting with Gershkovich on X, praising the journalist’s resilience during his...

Apple Inc (NASDAQ:AAPL) is looking to further cement its place in the artificial intelligence space through an investment in OpenAI. What To Know: Apple is in talks to take a stake in Sam Altman’s OpenAI, the company behind the popular ChatGPT AI chatbot, according to a new report from the...

The aircraft transporting Wall Street Journal reporter Evan Gershkovich, U.S. Marine Paul Whelan, and journalist Alsu Kurmasheva has landed in Washington, D.C., as reported by Andrew Roth, Global Affairs Correspondent for The Guardian on X. Plane carrying Evan Gershkovich Paul Whelan and Alsu...

Wall Street Journal reporter Evan Gershkovich has been sentenced to 18 years in prison in a Russian trial denounced by his employer and President Joe Biden. What Happened: The Journal reported that Gershkovich, who was arrested in 2023, was sentenced by a Russian court to 18 years in prison...

KKR & Co Inc (NYSE:KKR) shares are trading lower Tuesday. A new report suggests the company is making a big bet on rising rents. What To Know: According to a Wall Street Journal report, KKR has made its largest purchase of apartment buildings ever, suggesting the private-equity firm...

Editor’s Note: The headline for this article has been updated. According to a new report, German media company Axel Springer is considering an acquisition of The Wall Street Journal, expanding its already significant presence in the United States. The company currently owns Insider, Politico...

Shockwave Medical, Inc. (NASDAQ:SWAV) shares are trading higher Tuesday following a report suggesting Johnson & Johnson (NYSE:JNJ) is in talks to acquire the company. The Details: According to a report from the Wall Street Journal, people familiar with the matter say that a deal to acquire the...

Tension between the White House and the Drug Enforcement Administration (DEA) over marijuana rescheduling seems to be increasing, according to a Wall Street Journal report noting that some DEA officials are resisting this change on the basis that cannabis' "medicinal benefits remain unproven and...

Diabetes treatments such as Ozempic and Mounjaro became the blockbuster drugs of 2023 thanks to their popularity as weight-loss remedies. Prices for a month’s supply of these drugs were high then, and in 2024 their manufacturers have raised them higher still. According to data by 46brooklyn...